Home › Ovarian Epithelial Carcinoma › Washington › Seattle
Ovarian Epithelial Carcinoma clinical trials in Seattle, WA
4 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
RecruitingPhase 3
- Research Site, Seattle
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RecruitingPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
RecruitingObservational study
- The Swedish Hospital, Seattle
A Study of NX-1607 in Adults With Advanced Malignancies
RecruitingPhase 1
- Fred Hutchinson Cancer Center, Seattle
Ovarian Epithelial Carcinoma trials in other cities
- New York City, NY10 studies
- Boston, MA8 studies
- Durham, NC8 studies
- Cleveland, OH7 studies
- Houston, TX7 studies
- Baltimore, MD6 studies
- Chicago, IL6 studies
- Philadelphia, PA6 studies
- Salt Lake City, UT6 studies
- Edison, NJ5 studies
- Los Angeles, CA5 studies
- Minneapolis, MN5 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer55 studies
- Cancer (all types)48 studies
- Prostate Cancer45 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Breast Cancer37 studies
- Colorectal Cancer35 studies
- Lung Cancer34 studies
- Ovarian Cancer29 studies
- Pancreatic Cancer22 studies
- Multiple Myeloma22 studies
- Acute Lymphoblastic Leukemia22 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.